United States News All stories

PayPal Holdings (NASDAQ:PYPL) reportedly received a $60.50-per-share offer from Stripe and Advent International, valuing it above $53 billion.

Winmark (NASDAQ:WINA) reported Q2 2026 net income of $10.4 million and diluted earnings of $2.81 per share.

First Horizon (NYSE:FHN) reported a second-quarter net income available to common shareholders of $260 million alongside an earnings per share of $0.54.

Cintas (NASDAQ:CTAS) reported fiscal Q4 2026 net income of $511 million and diluted EPS of $1.26 on revenue of $2.91 billion.

VivoSim Labs (NASDAQ:VIVS) received $5 million from Eli Lilly (NYSE:LLY) after first Phase 2 dosing and could earn another $45 million.

Community Trust Bancorp (NASDAQ:CTBI) reported record Q2 2026 net income of $29.6 million and basic earnings of $1.64 per share.

Eos Energy Enterprises (NASDAQ:EOSE) expects record Q2 revenue of $68–$69 million as shipments more than tripled year over year.

Intensity Therapeutics (NASDAQ:INTS) restarted dosing in its 61-patient INVINCIBLE-4 trial, testing INT230-6 before standard treatment for presurgical TNBC.

Halliburton (NYSE:HAL) announced it secured a multi-year contract from Aramco to support unconventional gas development programs in Saudi Arabia.

Sify Technologies (NASDAQ:SIFY) reported Q1 FY2026-27 revenue of ₹12.352 billion, up 15%, with a ₹65 million profit.

Kaspi.kz (NASDAQ:KSPI) announced it completed the acquisition of Rabobank A.Ş. to expand its digital banking operations for its regional network of 25 million consumers.

Conagra Brands (NYSE:CAG) reported Q4 fiscal 2026 net sales of $2.9 billion, a diluted loss of $3.37 per share and an annualized dividend cut to $0.70.

Morgan Stanley (NYSE:MS) reported record Q2 2026 net revenue of $21.3 billion and diluted EPS of $3.46 as its major business divisions expanded.

Bruker (NASDAQ:BRKR) acquired DISQVER, an mNGS platform that can analyze blood-derived cell-free DNA for more than 11,000 microbes within 24 hours.

Axsome Therapeutics (NASDAQ:AXSM) announced the FDA accepted its New Drug Application for narcolepsy treatment AXS-12, setting a 2027 target date.

Veradermics (NYSE:MANE) reported that its VDPHL01 treatment produced an average increase of up to 23.3 hairs per square centimeter in female patients over six months.

Highway Holdings (NASDAQ:HIHO) reported fiscal 2026 revenue of $4.8 million and a shareholder-attributable net loss of $1.5 million, or $0.33 per share.

Pediatrix Medical Group (NYSE:MD) said its second-quarter payor mix remained stable and reaffirmed its $280–$300 million 2026 Adjusted EBITDA outlook.

BNY (NYSE:BNY) reported second-quarter revenue of $5.7 billion alongside an adjusted earnings per share of $2.45.

VCI Global (NASDAQ:VCIG) reported fiscal 2025 revenue of $26.1 million, down 6.2%, and a net loss attributable to shareholders of $30.3 million.

PNC (NYSE:PNC) reported a second-quarter net income of $2.1 billion and a record total revenue of $6.9 billion.

Johnson & Johnson (NYSE:JNJ) reported second-quarter sales of $25.3 billion alongside a reported earnings per share of $2.27.

Fractyl Health (NASDAQ:GUTS) reported one-year REMAIN-1 data showing 7.8% weight regain with Revita versus 13% with sham in 45 participants.

BlackRock (NYSE:BLK) reported second-quarter revenue of $7.08 billion as total assets surpassed $15 trillion for the first time.